Skip to main content
. 2018 May 21;2018:6463807. doi: 10.1155/2018/6463807

Figure 4.

Figure 4

Effect of nonsterol isoprenoids and soluble cholesterol treatments on Beclin 1 and MAP LC3-Ib/MAP LC3-IIb and RAP GTPase in C2C12 myoblasts affected by statins or MβCD.